We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.6B
AUM Growth
+$370M
(+2%)
Cap. Flow
-$1.05B
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
1,286
New
95
Increased
394
Reduced
580
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.1M |
| 2 |
Amazon
AMZN
|
+$37.3M |
| 3 |
Agilent Technologies
A
|
+$34.9M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$34.7M |
| 5 |
Netflix
NFLX
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$132M |
| 2 |
Cencora
COR
|
+$65.6M |
| 3 |
Biogen
BIIB
|
+$53.3M |
| 4 |
Applied Materials
AMAT
|
+$44.9M |
| 5 |
Dollar General
DG
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.39% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.34% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Broadstone Net Lease
BNL
$4.29B
| $66.2M | 0.36% |
3,616,519
-408,700
| -10% | -$7.55M |
|
77
Dropbox
DBX
$7.13B
| $64M | 0.34% |
2,399,853
+128,170
| +6% | +$3.08M |
|
78
Ametek
AME
$55.7B
| $63.8M | 0.34% |
499,180
+12,341
| +3% | +$1.49M |
|
79
Monster Beverage
MNST
$93.2B
| $62.9M | 0.34% |
1,380,884
+21,694
| +2% | +$972K |
|
80
CDW
CDW
$17.6B
| $62.6M | 0.34% |
377,771
-271,817
| -42% | -$40.6M |
|
81
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.25B
| $61.6M | 0.33% |
480,590
-7,702
| -2% | -$979K |
|
82
Walmart Inc
WMT
$889B
| $60.9M | 0.33% |
1,345,815
-77,667
| -5% | -$3.6M |
|
83
Intercontinental Exchange
ICE
$84.1B
| $58.4M | 0.31% |
522,996
-214,833
| -29% | -$24.4M |
|
84
Take-Two Interactive
TTWO
$45.3B
| $58.1M | 0.31% |
328,552
-778
| -0.2% | -$147K |
|
85
iShares Core S&P 500 ETF
IVV
$869B
| $57.2M | 0.31% |
143,733
+397
| +0.3% | +$154K |
|
86
Union Pacific
UNP
$178B
| $56.4M | 0.3% |
256,012
-25,514
| -9% | -$5.36M |
|
87
American Express
AXP
$226B
| $56.4M | 0.3% |
398,921
+25,877
| +7% | +$3.42M |
|
|
88
Biogen
BIIB
$29.5B
| $55.2M | 0.3% |
197,252
-197,559
| -50% | -$53.3M |
|
|
89
Dollar General
DG
$27.2B
| $55M | 0.3% |
271,615
-222,016
| -45% | -$44.1M |
|
|
90
Thermo Fisher Scientific
TMO
$208B
| $54.9M | 0.3% |
120,302
+72,662
| +153% | +$34.7M |
|
91
Northern Trust
NTRS
$22.4B
| $53.3M | 0.29% |
507,473
-303
| -0.1% | -$29.7K |
|
92
Tractor Supply
TSCO
$16.7B
| $53M | 0.29% |
1,495,255
-482,230
| -24% | -$15.4M |
|
93
CVS Health
CVS
$137B
| $52.5M | 0.28% |
697,951
+14,438
| +2% | +$1.05M |
|
94
AbbVie
ABBV
$454B
| $52M | 0.28% |
480,685
-1,386
| -0.3% | -$148K |
|
|
SCHW
95
Charles Schwab
SCHW
$181B
| $52M | 0.28% |
797,675
+11,812
| +2% | +$716K |
|
96
Visa
V
$689B
| $51.2M | 0.28% |
242,033
+84,581
| +54% | +$17.8M |
|
97
Dollar Tree
DLTR
$24.1B
| $51.2M | 0.28% |
447,089
+10,549
| +2% | +$1.13M |
|
98
Adobe
ADBE
$94.5B
| $50.4M | 0.27% |
105,971
-294
| -0.3% | -$137K |
|
99
Cardinal Health
CAH
$53.7B
| $49.8M | 0.27% |
819,519
+569,696
| +228% | +$31.4M |
|
100
TJX Companies
TJX
$173B
| $49.6M | 0.27% |
750,291
+7,190
| +1% | +$481K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2021 Portfolio in Review
As of Q1 2021, Glenmede Trust held 1,286 positions worth $18.6B, up 2% from $18.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust withdrew a net $1.05B in Q1 2021, closing 90 positions and reducing 580 holdings. Its most notable exit was Coherent, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Rollins worth $29.6M.
- Glenmede Trust's largest Q1 2021 buy was Rollins: 860,755 shares worth $29.6M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $42.1M increase.
- Glenmede Trust's biggest Q1 2021 reduction was Progressive, cutting an estimated $132M.
- Glenmede Trust fully exited Coherent in Q1 2021, selling an estimated $32.9M.
- Glenmede Trust's ten largest holdings make up 20% of its $18.6B portfolio in Q1 2021.
- Glenmede Trust opened 95 new positions and closed 90 in Q1 2021.
- Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $18.6B.
Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.